GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Durect Corp (NAS:DRRX) » Definitions » Cyclically Adjusted PB Ratio

Durect (Durect) Cyclically Adjusted PB Ratio : 0.54 (As of Apr. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Durect Cyclically Adjusted PB Ratio?

As of today (2024-04-28), Durect's current share price is $0.9313. Durect's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $1.73. Durect's Cyclically Adjusted PB Ratio for today is 0.54.

The historical rank and industry rank for Durect's Cyclically Adjusted PB Ratio or its related term are showing as below:

DRRX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.29   Med: 3.96   Max: 16.63
Current: 0.54

During the past years, Durect's highest Cyclically Adjusted PB Ratio was 16.63. The lowest was 0.29. And the median was 3.96.

DRRX's Cyclically Adjusted PB Ratio is ranked better than
84.7% of 647 companies
in the Drug Manufacturers industry
Industry Median: 1.75 vs DRRX: 0.54

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Durect's adjusted book value per share data for the three months ended in Dec. 2023 was $0.487. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.73 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Durect Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Durect's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Durect Cyclically Adjusted PB Ratio Chart

Durect Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.06 11.43 4.56 1.74 0.34

Durect Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.74 2.35 2.66 1.37 0.34

Competitive Comparison of Durect's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Durect's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Durect's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Durect's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Durect's Cyclically Adjusted PB Ratio falls into.



Durect Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Durect's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.9313/1.73
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Durect's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Durect's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.487/129.4194*129.4194
=0.487

Current CPI (Dec. 2023) = 129.4194.

Durect Quarterly Data

Book Value per Share CPI Adj_Book
201403 2.684 99.695 3.484
201406 2.246 100.560 2.891
201409 2.075 100.428 2.674
201412 1.628 99.070 2.127
201503 1.329 99.621 1.727
201506 1.898 100.684 2.440
201509 1.428 100.392 1.841
201512 1.222 99.792 1.585
201603 0.828 100.470 1.067
201606 1.395 101.688 1.775
201609 0.934 101.861 1.187
201612 0.590 101.863 0.750
201703 0.229 102.862 0.288
201706 -0.125 103.349 -0.157
201709 0.676 104.136 0.840
201712 1.425 104.011 1.773
201803 1.881 105.290 2.312
201806 1.745 106.317 2.124
201809 1.611 106.507 1.958
201812 1.234 105.998 1.507
201903 0.885 107.251 1.068
201906 1.193 108.070 1.429
201909 1.145 108.329 1.368
201912 1.171 108.420 1.398
202003 0.719 108.902 0.854
202006 1.821 108.767 2.167
202009 1.708 109.815 2.013
202012 1.971 109.897 2.321
202103 3.595 111.754 4.163
202106 3.229 114.631 3.646
202109 2.814 115.734 3.147
202112 2.538 117.630 2.792
202203 2.091 121.301 2.231
202206 1.611 125.017 1.668
202209 1.530 125.227 1.581
202212 1.097 125.222 1.134
202303 0.627 127.348 0.637
202306 0.223 128.729 0.224
202309 0.505 129.860 0.503
202312 0.487 129.419 0.487

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Durect  (NAS:DRRX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Durect Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Durect's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Durect (Durect) Business Description

Industry
Traded in Other Exchanges
Address
10260 Bubb Road, Cupertino, CA, USA, 95014
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
Executives
Judith J. Robertson director 10260 BUBB ROAD, CUPERTINO CA 95014
Gail J Maderis director 364 LOMBARD ST., SAN FRANCISCO CA 94133
Timothy M. Papp officer: Chief Financial Officer C/O DURECT CORPORATION, 10260 BUBB ROAD, CUPERTINO CA 95014
Gail M Farfel director 142 TEMPLE STREET, SUITE 205, NEW HAVEN CT 06510
Mohammad Azab director C/O SUPERGEN, INC., 4140 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568
Peter S Garcia director ALX ONCOLOGY HOLDINGS INC., 866 MALCOLM ROAD, SUITE 100, BURLINGAME CA 94010
Simon X Benito director 967 LAWRENCE AVE, WESTFIELD NJ 07090
Norman Sussman officer: Chief Medical Officer C/O DURECT CORP., 10260 BUBB ROAD, CUPERTINO CA 95014
Bleichroeder Lp 10 percent owner 1345 AVENUE OF THE AMERICAS, 47TH FLOOR, NEW YORK NY 10105
Judy R Joice officer: Sr. VP Operations & Corp QA 10260 BUBB ROAD, CUPERTINO CA 95014
21 April Fund Lp 10 percent owner 1345 AVENUE OF THE AMERICAS, 47TH FLOOR, New York NY 10105
Jon S Saxe director FIRST HORIZON PHARMACEUTICAL CORP, 660 HEMBREE PKWY STE 106, ROSWELL GA 30076
Michael Arenberg officer: Chief Financial Officer 10260 BUBB ROAD, CUPERTINO CA 95014
James E Brown director, officer: President & CEO 10240 BUBB RD, CUPERTINO CA 95014
First Eagle Investment Management, Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105